- Business
- Chemring Group PLC is a United Kingdom-based technology solutions company that develops and manufactures advanced products and services for the aerospace, defence and security markets. The company operates through two primary segments, Sensors & Information, which provides consulting and technology services to address security-critical issues along with electronic countermeasures and biological threat detection equipment; and Countermeasures & Energetics, which produces expendable countermeasures for air and sea platforms, cartridge and propellant actuated devices, pyrotechnic devices for satellite launch and deployment, missile components, propellants, separation sub-systems, actuators and energetic materials. Its offerings also encompass four key market sectors including aircraft, ship and land platform protection against guided missile threats; equipment to detect and disable improvised explosive devices, unexploded ordnance, electronic warfare and chemical or biological threats; pyrotechnics and munitions for navy, army and air force applications; and energetic systems such as propellants, explosives and components for the space sector.
Chemring Group serves national defence organizations, security and law enforcement agencies, and commercial markets including space and transport, with customers spanning the UK Ministry of Defence, US Department of Defense and international partners; it generates a substantial portion of revenue from North America, alongside operations in Europe, the Middle East, Asia-Pacific and the Americas. Founded in 1905 and headquartered at Roke Manor, Old Salisbury Lane, Romsey, Hampshire SO51 0ZN, United Kingdom, the company maintains approximately 1,700-2,672 employees and trades on the London Stock Exchange under the ticker CHG.L as a FTSE 250 constituent.
In recent developments, Chemring completed the acquisition of Landguard Systems in September 2025 for up to £20 million, enhancing its Roke business with tracking devices across iridium, cellular and RF technologies and supporting a £300 million international sales pipeline in cyber and electromagnetic activities. The company signed a 15-year partnering agreement in June 2024 with Northrop Grumman for HMX energetic material supply used in missile programmes, accompanied by an initial $83 million delivery order commencing in fiscal 2026. It increased its Energetics capacity expansion investment from £120 million to £200 million excluding grants, with £70 million in capital expenditure deployed by October 2024 amid record order book growth to £1,351 million as of January 2025, reflecting sustained demand and long-term customer contracts through subsidiaries like Chemring Nobel.